Salipro Biotech AB

Salipro Biotech AB
About Us
Contacts
Follow us:
Share:
Subscribe:

About Us

Salipro Biotech AB is a privately held biotech company focused on unlocking challenging drug targets for the development of next-generation therapeutics. The company is headquartered in Stockholm, Sweden with a fully owned IP portfolio that covers the Salipro® platform technology for the stabilization of membrane proteins. To date, Salipro Biotech has signed multiple research collaborations with top-tier pharma and biotech companies. Through in-house and partnered pipelines, Salipro Biotech AB accelerates the discovery of novel drugs.

Contacts

Visiting address
Salipro Biotech AB Teknikringen 38A 114 28 Stockholm Sweden

Links

Salipro Biotech

Pick a time period -

Tags ( Active)

All Regulatory Non-Regulatory

Salipro Biotech Expands Global Intellectual Property Portfolio with Granted Patents in Australia and Singapore

Thu, Dec 05, 2024 09:00 CET

Salipro Biotech strengthens its global intellectual property portfolio with granted patents in Singapore and Australia, protecting its proprietary Salipro[®] platform technology to enable the development of therapeutics against challenging drug targets.Stockholm, Sweden, December 5, 2024 – Salipro Biotech AB, a Swedish biotechnology company focused on advancing drug discovery for challenging drug targets, today announced the issuance of granted patents in both Singapore and Australia for its Salipro[®] platform technology, a novel and proprietary method for directly isolating and purifying

There are no items matching the current filter

There are no more items matching the current filter

Back to top

Share

About Us

Contacts

Links

Salipro Biotech Expands Global Intellectual Property Portfolio with Granted Patents in Australia and Singapore

Subscribe